Veriphi's Mission
Save Lives. Prevent IV Drug Error.
Veriphi is an exciting medical device start-up whose mission is to help save the thousands of lives of people who die annually from intravenous medication error. The company has developed a revolutionary solution to improve medication safety through the verification of intravenous (IV) drugs. By preventing errors and improving governance around medication delivery, Veriphi will save thousands of lives annually and reduce healthcare costs.
Enquire About a Free Trial
Veriphi Stats
Patents
Veriphi has 7 US patents, with 22 granted in other overseas jurisdictions including 2 in China.
Performance
Veriphi’s performance target is 99.9% drug identification accuracy and less than 5% drug concentration error. Veriphi has achieved this in recent trials on a suite of 6 drugs.
Compliance
International laboratory device compliance has been granted.
Cloud Database
The Veriphi cloud database provides a unique level of transparency regarding medication safety & drug delivery.
Investment
Veriphi has raised NZ$9m. With this money Veriphi has achieved commercially viable results, IEC approvals, a sizeable patent portfolio, and engagement with customers. The company is now seeking to secure a NZ$5m Series A investment round.
Global Interest
Veriphi is now poised to expand internationally with interest in New Zealand Australia, and the United States.